Mahamar, A., Sanogo, K., Sidibe, Y., Diarra, K., Samassekou, M., Attaher, O., . . . Hill, A. V. S. (2024). Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: A multicentre, double-blind, randomised, phase 3 trial. The Lancet, 403(10426), 533-544. https://doi.org/10.1016/S0140-6736(23)02511-4

Mahamar, Almahamoudou, et al. "Safety and Efficacy of Malaria Vaccine Candidate R21/Matrix-M in African Children: A Multicentre, Double-blind, Randomised, Phase 3 Trial." The Lancet 403, no. 10426 (2024): 533-544. https://doi.org/10.1016/S0140-6736(23)02511-4.

Mahamar, Almahamoudou, et al. "Safety and Efficacy of Malaria Vaccine Candidate R21/Matrix-M in African Children: A Multicentre, Double-blind, Randomised, Phase 3 Trial." The Lancet, vol. 403, no. 10426, 2024, pp. 533-544, https://doi.org/10.1016/S0140-6736(23)02511-4.